A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group study
- 15 November 1992
- Vol. 70 (10) , 2547-2551
- https://doi.org/10.1002/1097-0142(19921115)70:10<2547::aid-cncr2820701025>3.0.co;2-f
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- In vitro killing of human malignant mesothelioma by photodynamic therapyJournal of Surgical Research, 1990
- Phase II Evaluation of Recombinant Interferon-β (LFN-βser) in Patients with Diffuse Mesothelioma: A Southwest Oncology Group StudyJournal of Interferon Research, 1990
- Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary resultsCancer Treatment Reviews, 1989
- A phase II trial of ifosfamide/mesna with doxorubicin for malignant mesotheliomaEuropean Journal of Cancer and Clinical Oncology, 1989
- Activity of pirarubicin (4′-o-tetrahydropyranyladriamycin) in malignant mesotheliomaCancer, 1989
- A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group StudyInvestigational New Drugs, 1988
- Malignant Pleural Mesothelioma: Phase II Pilot Study of Ifosfamide and Mesna*JNCI Journal of the National Cancer Institute, 1988
- Treatment of six cases of mesothelioma with doxorubicin and cisplatinCancer, 1983
- High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcomaCancer Treatment Reviews, 1983
- The Enhanced Therapeutic Effect of cis-Platinum (II) Diamminodichloride against L1210 Leukemia when Combined with Cyclophosphamide or 1,2-bis(3,5-Dioxopiperazine-1-yl)propane or Several other Antitumor AgentsChemotherapy, 1973